COLL vs USB
Collegium Pharmaceutical Inc (COLL) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the COLL and USB stock pages for the full models.
Not investment advice.